CD8A and neuroblastoma: Results from the present ex vivo study indicate that induction of neuroblastoma cell death by doxorubicin may enhance survival of tumor-bearing mice in vivo and promote proliferation of CD8α+ lymphocytes and IFN-γ production in vitro.